Members of the Big Ten Cancer Research Consortium steering committee appointed Robert Kratzke as the committee's first chair and Ruth O'Regan as its vice chair. Each will serve a one-year term, with O'Regan serving as chair in the subsequent year.xxx:moreKratzke is
The Patient-Centered Outcomes Research Institute Board of Governors has green-lighted nearly $42 million to fund 19 new studies comparing which healthcare approaches work best.
The year got off to a bad start for some employees of MD Anderson Cancer Center.
As administrations change, cancer research stands in an unusually strong position, NCI Acting Director Douglas Lowy said in an interview with The Cancer Letter.
After leaving the White House, Vice President Joe Biden plans to consolidate his work on the Cancer Moonshot into an independent, nonprofit organization, while juggling non-cancer programs at two universities.
ST. JUDE CHILDREN'S RESEARCH HOSPITAL opened its Red Frog Events Proton Therapy Center, the first proton therapy center in the world dedicated solely to children with cancer.
The moonshot, The Cancer Letter's biggest area of coverage of 2016, continues into 2017.
In a 17-institution inspection sparked by reports of patient harm and death resulting from power morcellators and contaminated duodenoscopes, FDA found that nearly all hospitals surveyed either failed to report adverse events or didn't have proper reporting and documentation procedures in place.
Rep. Mike Fitzpatrick (R-Pa.), a staunch advocate for mandating individual reporting of adverse events by physicians
JEFFREY DREBIN was named chair of surgery at Memorial Sloan Kettering Cancer Center, a position he will assume early next year. He is the chair of the Department of Surgery at Penn Medicine and the 14th John Rhea Barton Professor of Surgery at the Perelman School of Medicine.
